| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 |
| Total Revenue | 1,316 | 1,011 | 989 | 1,159 |
| Cost of Revenue | 579 | 551 | 581 | 623 |
|
| Gross Profit | 738 | 461 | 408 | 536 |
|
| Operating Expenses |
| Research Development | 102 | 104 | 135 | 148 |
| Selling General and Administrative | 648 | 716 | 668 | 685 |
| Non Recurring |
-
|
-
|
-
|
-
|
| Others |
-
|
-
|
-
|
-
|
| |
| Total Operating Expenses |
-
|
-
|
-
|
-
|
|
|
| Operating Income or Loss | (13) | (360) | (395) | (297) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | 97 | 20 | 25 | 34 |
| Earnings Before Interest And Taxes | 84 | (340) | (369) | (263) |
| Interest Expense |
-
|
-
|
-
|
-
|
| Income Before Tax | 84 | (340) | (369) | (263) |
| Income Tax Expense | (17) | (2) | 0 | 4 |
| Minority Interest |
-
|
-
|
-
|
-
|
| |
| Net Income From Continuing Ops | 102 | (338) | (369) | (267) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
| Net Income | 102 | (338) | (369) | (267) |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares | $102 | ($338) | ($369) | ($267) |
0.20% Nasdaq 
0.02 (24.05%) 
Income Statement
